drugset

drugset / Trial / NCT00310453

Tolerability of ALK Grass Tablet in Children

NCT00310453 ↗

Phase 1 Completed 32 enrolled ALK-Abelló A/S

RandomizedParallel-groupDouble-blind

Summary

The purpose of this trial is to assess whether the ALK Grass tablet treatment is safe to use in children aged 5-12 years

Timeline

Start: 2006-03
Primary completion: —
Completion: 2006-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ALK Grass tablet	Unknown	—	—

Indications